Advertisement
Advertisement

APUS

A

Apimeds Pharmaceuticals US, Inc.

2.21
USD
Sponsored
+0.14
+6.81%
Jan 23, 16:00 UTC -5
Closed
exchange

After-Market

2.25

+0.04
+1.76%

Apimeds Pharmaceuticals US, Inc. Financial Snapshot

Market Cap
28.30M
Beta
--
Earnings Per Share (EPS)
--
Price-to-Book (P/B) Ratio
3.19
Operating Margin
--
Total Debt/Equity (D/E)
6.13%
P/E Ratio
--
Return on Equity (ROE)
-139.57%
Current Ratio
8.34%
Free Cash Flow
-5.14M

Trending Stocks

Advertisement